Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
Robert Thimme
Department of Medicine II, University Medical Center Freiburg, Freiburg, Germany
Search for more papers by this authorMarco Binder
Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany
Search for more papers by this authorCorresponding Author
Ralf Bartenschlager
Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany
Correspondence: Ralf Bartenschlager, Department of Infectious Diseases, Molecular Virology, Heidelberg University, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany. Tel.: +49 6221 564225; fax: +49 6221 564570; e-mail: [email protected]Search for more papers by this authorRobert Thimme
Department of Medicine II, University Medical Center Freiburg, Freiburg, Germany
Search for more papers by this authorMarco Binder
Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany
Search for more papers by this authorCorresponding Author
Ralf Bartenschlager
Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany
Correspondence: Ralf Bartenschlager, Department of Infectious Diseases, Molecular Virology, Heidelberg University, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany. Tel.: +49 6221 564225; fax: +49 6221 564570; e-mail: [email protected]Search for more papers by this authorAbstract
Effective innate and adaptive immune responses are essential for the control of hepatitis C virus (HCV) infection. Indeed, elimination of HCV during acute infection correlates with an early induction of innate and a delayed induction of adaptive immune responses. However, in the majority of acutely HCV-infected individuals, these responses are insufficient to clear the virus and persistence develops. In recent years, different mechanisms responsible for the failure of innate and adaptive immune responses have been identified. These include the proteolytic cleavage of molecules playing key roles in the induction of the interferon response, manipulation of interferon-induced effector proteins, interference with CD8+ T-cell function or immune escape in T- and B-cell epitopes. In this review, we discuss the possible roles of innate and adaptive immune responses in HCV clearance and the different evasion strategies used by the virus to escape these immune responses.
References
- Abel M, Sene D, Pol S, Bourliere M, Poynard T, Charlotte F, Cacoub P & Caillat-Zucman S (2006) Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44: 1607–1616.
- Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A, Abrignani S, Mondelli MU & Barnaba V (2004) Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113: 963–972.
- Ahlenstiel G, Titerence RH, Koh C et al. (2010) Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138: 325–335.
- Ait-Goughoulte M, Kanda T, Meyer K, Ryerse JS, Ray RB & Ray R (2008) Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol 82: 2241–2249.
- Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P, Missale G, Ferrari C & Khakoo SI (2010) Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138: 1536–1545.
- Arnaud Nl, Dabo SP, Maillard P et al. (2010) Hepatitis C virus controls interferon production through PKR activation. PLoS ONE 5: e10575.
- Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR & Barber GN (2000) Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13: 129–141.
- Bankwitz D, Steinmann E, Bitzegeio J et al. (2010) Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J Virol 84: 5751–5763.
- Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, Emerson SU, Cosset FL & Purcell RH (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. P Natl Acad Sci USA 100: 14199–14204.
- Bellecave P, Sarasin-Filipowicz M, Donze O et al. (2010) Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology 51: 1127–1136.
- Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsacker F, Blum HE, Pircher H & Thimme R (2007) Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 81: 945–953.
- Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE, Pircher H & Thimme R (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6: e1000947.
- Bigger CB, Brasky KM & Lanford RE (2001) DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75: 7059–7066.
- Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, Lemon SM & Lanford RE (2004) Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78: 13779–13792.
- Billerbeck E, Kang YH, Walker L et al. (2010) Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. P Natl Acad Sci USA 107: 3006–3011.
- Binder M, Kochs G, Bartenschlager R & Lohmann V (2007) Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46: 1365–1374.
- Binder M, Eberle F, Seitz S, Mucke N, Huber CM, Kiani N, Kaderali L, Lohmann V, Dalpke A & Bartenschlager R (2011) Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 286: 27278–27287.
- Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA & Wherry EJ (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29–37.
- Blindenbacher A, Duong FH, Hunziker L et al. (2003) Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 124: 1465–1475.
- Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC & Haussinger D (2003) IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 17: 488–490.
- Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, Blum HE, von Weizsacker F & Thimme R (2005) T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79: 7860–7867.
- Bowen DG & Walker CM (2005) Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 201: 1709–1714.
- Bowen DG, Shoukry NH, Grakoui A et al. (2008) Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection. J Virol 82: 5109–5114.
- Brimacombe CL, Grove J, Meredith LW et al. (2011) Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J Virol 85: 596–605.
- Brown EA, Zhang H, Ping LH & Lemon SM (1992) Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20: 5041–5045.
- Bukh J, Apgar CL, Govindarajan S, Emerson SU & Purcell RH (2001) Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a. J Viral Hepat 8: 228–231.
- Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C & Nelson DR (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062–1071.
- Callendret B & Walker C (2011) A siege of hepatitis: immune boost for viral hepatitis. Nat Med 17: 252–253.
- Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A & Chisari FV (1997) Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 100: 2376–2385.
- Cheent K & Khakoo SI (2011) Natural killer cells and hepatitis C: action and reaction. Gut 60: 268–278.
- Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, Heathcote J, Edwards AM & McGilvray ID (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437–1444.
- Cheng G, Zhong J & Chisari FV (2006) Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. P Natl Acad Sci USA 103: 8499–8504.
- Chisari FV (2005) Unscrambling hepatitis C virus–host interactions. Nature 436: 930–932.
- Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P & Walker CM (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10: 439–449.
- Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL & Ray SC (2005a) Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42: 104–112.
- Cox AL, Mosbruger T, Mao Q et al. (2005b) Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201: 1741–1752.
- Crispe IN (2011) Liver antigen-presenting cells. J Hepatol 54: 357–365.
- Crotta S, Stilla A, Wack A et al. (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195: 35–41.
- Crotta S, Brazzoli M, Piccioli D, Valiante NM & Wack A (2010) Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol 52: 183–190.
- David M (2010) Interferons and microRNAs. J Interferon Cytokine Res 30: 825–828.
- Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT & Walker BD (2002) Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584–12595.
- Dazert E, Neumann-Haefelin C, Bressanelli S et al. (2009) Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J Clin Invest 119: 376–386.
- Diegelmann J, Beigel F, Zitzmann K, Kaul A, Goke B, Auernhammer CJ, Bartenschlager R, Diepolder HM & Brand S (2010) Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS ONE 5: e15200.
- Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D & Pape GR (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006–1007.
- Diepolder HM, Gerlach JT, Zachoval R et al. (1997) Immunodominant CD4(+) T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71: 6011–6019.
- Dowd KA, Netski DM, Wang XH, Cox AL & Ray SC (2009) Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 136: 2377–2386.
- Dreux MN, Gastaminza P, Wieland SF & Chisari FV (2009) The autophagy machinery is required to initiate hepatitis C virus replication. P Natl Acad Sci USA 106: 14046–14051.
- Duong FH, Filipowicz M, Tripodi M, La Monica N & Heim MH. (2004) Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126: 263–277.
- Dupuis SP, Jouanguy E, Al Hajjar S et al. (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33: 388–391.
- Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, McKinney D, Sette A, Hughes AL & Walker CM (2001) The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15: 883–895.
- Falkowska E, Kajumo F, Garcia E, Reinus J & Dragic T (2007) Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J Virol 81: 8072–8079.
- Farag MMS, Weigand K, Encke J & Momburg F (2011) Activation of natural killer cells by hepatitis C virus particles in vitro. Clin Exp Immunol 163: 352–362.
- Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M & Purcell RH (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. P Natl Acad Sci USA 91: 7792–7796.
- Farci P, Shimoda A, Wong D, Cabezon T, DeGioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ & Purcell RH (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. P Natl Acad Sci USA 93: 15394–15399.
- Fitzmaurice K, Petrovic D, Ramamurthy N et al. (2011) Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. Gut 60: 1563–1571.
- Fleming VM, Harcourt G, Barnes E & Klenerman P (2010) Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection. J Gen Virol 91: 1396–1406.
- Fletcher NF, Yang JP, Farquhar MJ et al. (2010) Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 139: 1365–1374.
- Foy E, Li K, Wang C, Sumpter Jr R, Ikeda M, Lemon SM & Gale Jr M (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300: 1145–1148.
- Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU & Barnaba V (2009) PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551–564.
- Frese M, Pietschmann T, Moradpour D, Haller O & Bartenschlager R (2001) Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82: 723–733.
- Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O & Bartenschlager R (2002) Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35: 694–703.
- Fuller MJ, Shoukry NH, Gushima T, Bowen DG, Callendret B, Campbell KJ, Hasselschwert DL, Hughes AL & Walker CM (2010) Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection. Hepatology 51: 378–387.
- Gale M & Katze MG (1998) Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78: 29–46.
- Garaigorta U & Chisari FV (2009) Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6: 513–522.
- Gaudieri S, Rauch A, Park LP et al. (2006) Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol 80: 11094–11104.
- Ge D, Fellay J, Thompson AJ et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399–401.
- Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, Hoffmann R, Schirren CA, Santantonio T & Pape GR (1999) Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 117: 933–941.
- Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N & Rosen HR (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 81: 9249–9258.
- Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C & Doherty DG (2008) Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57: 1121–1128.
- Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR & Rosen HR (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 83: 9122–9130.
- Grafmüller S, Billerbeck E, Blum HE, Neumann-Haefelin C & Thimme R (2011) Differential antigen-specificity of hepatitis C virus specific IL-17- and IFN-γ-producing CD8+ T cells during chronic infection. J Inf Dis in press.
- Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM & Walker CM (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659–662.
- Gruner NH, Gerlach TJ, Jung MC et al. (2000) Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 181: 1528–1536.
- Guo JT, Sohn JA, Zhu Q & Seeger C (2004) Mechanism of the interferon alpha response against hepatitis C virus replicons. Virology 325: 71–81.
- von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P & McKeating JA (2007) Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132: 667–678.
- Haller O & Weber F (2007) Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol 316: 315–334.
- Heeg MH, Ulsenheimer A, Gruner NH et al. (2009) FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 137: 1280–1288.
- Heim MH, Moradpour D & Blum HE (1999) Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73: 8469–8475.
- Helbig KJ, Lau DT, Semendric L, Harley HA & Beard MR (2005) Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42: 702–710.
- Helle F, Goffard A, Morel V, Duverlie G, McKeating J, Keck ZY, Foung S, Penin F, Dubuisson J & Voisset C (2007) The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J Virol 81: 8101–8111.
- Hong X, Yu RB, Sun NX, Wang B, Xu YC & Wu GL (2005) Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 11: 7302–7307.
- Jo J, Aichele U, Kersting N et al. (2009) Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 136: 1391–1401.
- Jo J, Lohmann V, Bartenschlager R & Thimme R (2011) Experimental models to study the immunobiology of hepatitis C virus. J Gen Virol 92: 477–493.
- Jopling CL, Yi M, Lancaster AM, Lemon SM & Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577–1581.
- Kang JI, Kwon SN, Park SH, Kim YK, Choi SY, Kim JP & Ahn BY (2009) PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control. Virus Res 142: 51–56.
- Kaplan DE, Sugimoto K, Newton K et al. (2007) Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 132: 654–666.
- Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T et al. (2008) High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol 82: 3154–3160.
- Kawai T & Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373–384.
- Ke PY & Chen SS (2011) Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Invest 121: 37–56.
- Khakoo SI, Thio CL, Martin MP et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872–874.
- Kim AY, Kuntzen T, Timm J et al. (2011) Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 140: 686–696.
- Kimura Y, Gushima T, Rawale S, Kaumaya P & Walker CM (2005) Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. J Virol 79: 4870–4876.
- Knapp S, Warshow U, Hegazy D et al. (2010) Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 51: 1168–1175.
- Kuniholm MH, Kovacs A, Gao X et al. (2010) Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 51: 1514–1522.
- Lande R & Gilliet M (2010) Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann NY Acad Sci 1183: 89–103.
- Larkin J, Bost A, Glass JI & Tan SL (2006) Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons. J Interferon Cytokine Res 26: 854–865.
- Lauer GM & Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41–52.
- Lauer GM, Ouchi K, Chung RT et al. (2002) Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76: 6104–6113.
- Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P & Walker BD (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499–1512.
- Lee HK, Lund JM, Ramanathan B, Mizushima N & Iwasaki A (2007) Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315: 1398–1401.
- Li Y, Zhang T, Ho C, Orange JS, Douglas SD & Ho WZ (2004) Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 76: 1171–1179.
- Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale Jr M & Lemon SM (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. P Natl Acad Sci USA 102: 2992–2997.
- Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM & McKeating JA (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. P Natl Acad Sci USA 101: 10149–10154.
- Luquin E, Larrea E, Civeira MP, Prieto Js & Aldabe R (2007) HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway. Antiviral Res 76: 194–197.
- Major ME, Dahari H, Mihalik K, Puig M, Rice CM, Neumann AU & Feinstone SM (2004) Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 39: 1709–1720.
- Malathi K, Dong B, Gale Jr M & Silverman RH (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816–819.
- Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR & Rice CM (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131: 1887–1898.
- Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM & Dustin LB (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48: 1843–1850.
- Matloubian M, Concepcion RJ & Ahmed R (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056–8063.
- McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, Hegarty J, Lawlor E & Kelleher D (2004) Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40: 108–114.
- McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR & Rosen HR (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120: 4546–4557.
- Merani S, Petrovic D, James I et al. (2011) Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology 53: 396–405.
- Meyer-Olson D, Shoukry NH, Brady KW, Kim H, Olson DP, Hartman K, Shintani AK, Walker CM & Kalams SA (2004) Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med 200: 307–319.
- Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R & Tschopp J (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167–1172.
- Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F & Ferrari C (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98: 706–714.
- Montes-Cano MA, Caro-Oleas JL, Romero-Gómez M, Diago MS, Andrade R, Carmona I, Aguilar Reina J, Núñez-Roldán A & González-Escribano MF (2005) HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 66: 1106–1109.
- Nakamoto N, Kaplan DE, Coleclough J et al. (2008) Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134: 1927–1937.
- Nakamoto N, Cho H, Shaked A et al. (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5: e1000313.
- Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J & Cox A (2005) Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 41: 667–675.
- Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ & Perelson AS (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282: 103–107.
- Neumann-Haefelin C, McKiernan S, Ward S et al. (2006) Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43: 563–572.
- Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, Roggendorf M, Allen TM, Blum HE & Thimme R (2008) Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection. Hepatology 47: 1824–1836.
- Neumann-Haefelin C, Timm J, Schmidt J et al. (2010) Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology 51: 54–62.
- Northfield JW, Kasprowicz V, Lucas M et al. (2008) CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 47: 396–406.
- Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S & Mondelli MU (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151–1160.
- Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL & Cox AL (2010) Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138: 315–324.
- Osterlund PI, Pietil+ñ TE, Veckman V, Kotenko SV & Julkunen I (2007) IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179: 3434–3442.
- Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L, Missale G & Ferrari C (2007) Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45: 588–601.
- Pestka JM, Zeisel MB, Blaser E et al. (2007) Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. P Natl Acad Sci USA 104: 6025–6030.
- Pflugheber J, Fredericksen B, Sumpter Jr R, Wang C, Ware F, Sodora DL & Gale Jr M (2002) Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. P Natl Acad Sci USA 99: 4650–4655.
- Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP & Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882–886.
- Poenisch M & Bartenschlager R (2010) New insights into structure and replication of the hepatitis C virus and clinical implications. Semin Liver Dis 30: 333–347.
- Quinkert D, Bartenschlager R & Lohmann V (2005) Quantitative analysis of the hepatitis C virus replication complex. J Virol 79: 13594–13605.
- Radziewicz H, Ibegbu CC, Fernandez ML et al. (2007) Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81: 2545–2553.
- Radziewicz H, Ibegbu CC, Hon H et al. (2008) Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 82: 9808–9822.
- Randall RE & Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1–47.
- Rauch A, Laird R, McKinnon E, Telenti A, Furrer H, Weber R, Smillie D, Gaudieri S & Swiss HIV CS (2007) Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens 69(Suppl 1): 237–240.
- Rauch A, James I, Pfafferott K et al. (2009) Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 50: 1017–1029.
- Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E & Thomas DL (2005) Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 201: 1753–1759.
- Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745–1754.
- Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung RT, Amos C & Yunis EJ (2008) Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 45: 2429–2436.
- Rowan AG, Fletcher JM, Ryan EJ, Moran B, Hegarty JE, O'Farrelly C & Mills KH (2008) Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol 181: 4485–4494.
- Ruhl M, Knuschke T, Schewior K et al. (2011) CD8(+)T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology 140: 2064–2073.
- Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P & Alexander GJ (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79: 7852–7859.
- Sabo MC, Luca VC, Prentoe J et al. (2011) Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step. J Virol 85: 7005–7019.
- Saito T, Owen DM, Jiang F, Marcotrigiano J & Gale Jr M (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523–527.
- Saitoh T & Akira S (2010) Regulation of innate immune responses by autophagy-related proteins. J Cell Biol 189: 925–935.
- Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W & Heim MH (2008) Interferon signaling and treatment outcome in chronic hepatitis C. P Natl Acad Sci USA 105: 7034–7039.
- Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH & Filipowicz W (2009) Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31–33.
- Schindler C & Plumlee C (2008) Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 19: 311–318.
- Schlaphoff V, Lunemann S, Suneetha PV et al. (2011) Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 7: e1002045.
- Schlee M, Roth A, Hornung V et al. (2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25–34.
- Schmidt A, Schwerd T, Hamm W et al. (2009) 5′-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. P Natl Acad Sci USA 106: 12067–12072.
- Schmidt J, Thimme R & Neumann-Haefelin C (2011) Host genetics in immune-mediated hepatitis C virus clearance. Biomark Med 5: 155–169.
- Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P & Rice CM (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481–485.
- Schulze Zur Wiesch J, Lauer GM, Day CL et al. (2005) Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175: 3603–3613.
- Seifert U, Liermann H, Racanelli V et al. (2004) Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 114: 250–259.
- Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A & Klenerman P (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41: 1019–1028.
- Sene D, Levasseur F, Abel M et al. (2010) Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog 6: e1001184.
- Shepard CW, Finelli L & Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558–567.
- Sheppard P, Kindsvogel W, Xu W et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63–68.
- Shin EC, Park SH, Demino M et al. (2011) Delayed induction, not impaired recruitment of specific CD8(+) T cells, causes the late onset of acute hepatitis C. Gastroenterology 141: 686–695.
- Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, Reimann KA & Walker CM (2003) Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197: 1645–1655.
- Shrivastava S, Raychoudhuri A, Steele R, Ray R & Ray RB (2011) Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology 53: 406–414.
- Shuai K & Liu B (2005) Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 5: 593–605.
- Sir D & Ou JH (2010) Autophagy in viral replication and pathogenesis. Mol Cells 29: 1–7.
- Sir D, Chen WL, Choi J, Wakita T, Yen TS & Ou JH (2008) Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 48: 1054–1061.
- Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton Jr JR, Tester IA, Wang CC, Culbertson N, Vandenbark AA & Rosen HR (2008) Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. J Infect Dis 197: 46–57.
- Soderholm J, Ahlen G, Kaul A et al. (2006) Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55: 266–274.
- Sommereyns C, Paul S, Staeheli P & Michiels T (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017.
- Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizsacker F, Blum HE & Thimme R (2005) Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42: 828–837.
- Stegmann KA, Björkström NK, Veber H et al. (2010) Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138: 1885–1897.
- Su AI, Pezacki JP, Wodicka L et al. (2002) Genomic analysis of the host response to hepatitis C virus infection. P Natl Acad Sci USA 99: 15669–15674.
- Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ & Chang KM (2003) Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437–1448.
- Suppiah V, Moldovan M, Ahlenstiel G et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100–1104.
- Tacke R, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR & Hahn YS (2011) Myeloid suppressor cells induced by hepatitis C virus suppress T cell responses through the production of reactive oxygen species. Hepatology in press.
- Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, Isogawa M & Chisari FV (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. P Natl Acad Sci USA 107: 7431–7436.
- Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP & Rehermann B (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6: 578–582.
- Tanaka Y, Nishida N, Sugiyama M et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105–1109.
- Tardif KD, Mori K & Siddiqui A (2002) Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol 76: 7453–7459.
- Taylor DR, Shi ST, Romano PR, Barber GN & Lai MC (1999) Inhibition of the interferon-inducible protein kinase PKR by HCV E protein. Science 285: 107–110.
- Taylor DR, Puig M, Darnell ME, Mihalik K & Feinstone SM (2005) New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol 79: 6291–6298.
- Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, Lewinsohn DM, Tavis JE & Rosen HR (2005) Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201: 1725–1731.
- Thimme R, Oldach D, Chang KM, Steiger C, Ray SC & Chisari FV (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395–1406.
- Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH & Chisari FV (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. P Natl Acad Sci USA 99: 15661–15668.
- Thio CL, Gao X, Goedert JJ et al. (2002) HLA-Cw*04 and hepatitis C virus persistence. J Virol 76: 4792–4797.
- Thomas DL, Thio CL, Martin MP et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798–801.
- Timm J, Lauer GM, Kavanagh DG et al. (2004) CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200: 1593–1604.
- Timm J, Li B, Daniels MG et al. (2007) Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 46: 339–349.
- Timpe JM, Stamataki Z, Jennings A et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 17–24.
- Tseng CT & Klimpel GR (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195: 43–49.
- Urbani S, Amadei B, Cariani E, Fisicaro P, Orlandini A, Missale G & Ferrari C (2005) The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection. J Immunol 175: 7519–7529.
- Uzri D & Gehrke L (2009) Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83: 4174–4184.
- Walker CM (2010) Adaptive immunity to the hepatitis C virus. Adv Virus Res 78: 43–86.
- Wang C, Pflugheber J, Sumpter Jr R, Sodora DL, Hui D, Sen GC & Gale Jr M (2003) Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 77: 3898–3912.
- Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, Fleming KA, Banham AH & Klenerman P (2007) Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 47: 316–324.
- Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H & Rehermann B (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447–3458.
- Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Houghton M & Walker CM (1995) Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection. Princess Takamatsu Symp 25: 227–235.
- West AP, Shadel GS & Ghosh S (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11: 389–402.
- Witteveldt J, Evans MJ, Bitzegeio J et al. (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol 90: 48–58.
- Xie ZC, Riezu-Boj JI, Lasarte JJ, Guillen J, Su JH, Civeira MP & Prieto J (1998) Transmission of hepatitis C virus infection to tree shrews. Virology 244: 513–520.
- Xu X, Chen H, Cao X & Ben K (2007) Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol 88: 2504–2512.
- Yoneyama M & Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227: 54–65.
- Yoon JC, Shiina M, Ahlenstiel G & Rehermann B (2009) Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49: 12–21.
- Yoshimura A, Naka T & Kubo M (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454–465.
- Zeisel MB, Cosset FL & Baumert TF (2008) Host neutralizing responses and pathogenesis of hepatitis C virus infection. Hepatology 48: 299–307.
- Zeisel MB, Fofana I, Fafi-Kremer S & Baumert TF (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 54: 566–576.
- Zhang P, Wu CG, Mihalik K, Virata-Theimer ML, Yu MY, Alter HJ & Feinstone SM (2007) Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. P Natl Acad Sci USA 104: 8449–8454.
- Zignego AL, Giannini C, Monti M & Gragnani L (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39(Suppl 1): S38–S45.